FINWIRES · TerminalLIVE
FINWIRES

Machinery, Infra Service, Multi-Industry Companies Set for Positive Quarterly Prints, Truist Says

By
Machinery, Infra Service, Multi-Industry Companies Set for Positive Quarterly Prints, Truist Says

Upcoming quarterly results of major companies in the machinery, infrastructure services and multi-industry domains are poised to benefit from a continued expansion in the US manufacturing sector and strong demand trends, Truist Securities said Thursday.

The manufacturing sector has now expanded for six straight months following a three-year contraction, according to the brokerage.

"Demand trends remain strong across the group, with continued support from secular growth tailwinds associated with power, data center, (artificial intelligence), aerospace and defense, (heating, ventilation, and air conditioning), and infrastructure," Truist analysts, including Jamie Cook, said in a note to clients.

These are complemented by improving demand across construction, commercial vehicles, semiconductors, oil and gas, as well as mining, according to Cook.

"While farm equipment markets remain depressed in 2026, there is some optimism for market improvement above the trough heading into 2027," Cook wrote. "We expect order trends in the second quarter to remain strong and that strength in orders should begin to translate more into organic growth, which has lagged."

Within machinery, Caterpillar (CAT) is likely to deliver another strong quarter and beat sales and margin outlook, driven by power and construction business, as well as reaccelerating oil and gas, and mining divisions, according to the note.

"For farm equipment, we believe the focus will be more on the setup for 2027 and Deere's (DE) commentary on the early order program for 2027 after disappointing in 2026," Cook said.

Truist expects infrastructure solutions company Quanta Services (PWR) to post an earnings beat and raise guidance. Underappreciated data center and pipeline opportunities are likely key upside drivers for MasTec (MTZ), according to Truist. "MasTec has already communicated to the market confidence in its ability to grow (earnings per share) at a 20% (compound annual growth rate) through 2028," Cook wrote.

The brokerage said it would be buyers of Parker-Hannifin (PH) at existing levels.

"We believe (Parker-Hannifin's) modestly disappointing industrial incremental margins were contained in the last quarter and that the setup for (2027) is strong, with the potential to deliver healthy incrementals in both industrial and aerospace," Cook said.

Price: $956.71, Change: $-34.70, Percent Change: -3.50%

Related Articles

Australia's Perpetual Turns Down AU$2.45 Billion EQT Buyout Bid
US Markets

Australia's Perpetual Turns Down AU$2.45 Billion EQT Buyout Bid

Australian investment fund Perpetual (ASX:PPT) has turned down a takeover approach from Swedish private equity firm EQT AB, saying the proposal undervalued the financial services company, according to a Wednesday press release.Under the proposal, EQT-controlled Windflower Pte Limited offered to acquire all of Perpetual's shares for AU$21.64 apiece in cash, valuing the company at about AU$2.45 billion."The indicative proposal was highly conditional and did not adequately represent fair value for Perpetual shareholders in the context of a change of control transaction," the company said in a statement.The approach comes after Perpetual terminated an AU$2.2 billion deal with private equity firm KKR in 2025 to sell its wealth management and corporate trust businesses.The transaction was scrapped after an independent expert concluded it was not in the best interests of shareholders following an adverse tax ruling.Perpetual said it would instead pursue a separate sale of its wealth management business.The investment manager subsequently agreed to sell its wealth management business to Bain Capital for an upfront cash payment of AU$500 million, with additional performance-linked payments of up to AU$50 million.The company said the proceeds would be used to reduce debt and support growth in its asset management and corporate trust businesses.The latest proposal adds to a string of takeover attempts for the investment manager.Perpetual rejected an AU$1.7 billion bid from a consortium that included Regal Partners in 2022, before turning down an AU$3.1 billion offer from its largest shareholder, Washington H. Soul Pattinson, the following year.

ASX:PPT
Update: Alibaba, US Payments Partner to Pay $600 Million in Drug-Import Probe
US Markets

Update: Alibaba, US Payments Partner to Pay $600 Million in Drug-Import Probe

(Updates to remove the seeking comment line in the 9th paragraph, as Alibaba has since responded)Alibaba Group (HKG:9988) and its US payments processor, AUS Merchant Services, agreed to pay a combined $600 million to resolve an investigation by the US Justice Department into illegal pharmaceutical sales on the company's e-commerce platforms.The Chinese tech and e-commerce firm admitted that between January 2016 and December 2024, it failed to prevent roughly 80,000 product sales on Alibaba.com and AliExpress.com that involved unlawful imports of pharmaceuticals, controlled substances, listed chemicals and pill presses, according to a Wednesday notice from the Justice Department.In a statement issued to, Alibaba described the settlement as a "mutually satisfactory resolution with U.S. regulators.""This settlement reflects a thorough regulatory process with Alibaba's full cooperation and our commitment to best-in-class standards of control, policies, and measures against non-compliant product sales."The products involved in the investigation have a combined gross merchandise value exceeding $200 million, the DOJ said, adding that federal agents made more than 40 undercover purchases of illegal drugs and counterfeiting equipment during the probe.Separately, AUS admitted that from January 2020 to December 2023, it accepted US dollar-denominated wire and credit-card payments on behalf of overseas Alibaba merchants.Under a non-prosecution agreement, Alibaba will pay a $125 million criminal penalty and forfeit $200 million, while AUS, formerly known as Alipay US, will pay an $85 million penalty and forfeit $190 million.First Assistant U.S. Attorney Charles C. Calenda for the District of Rhode Island called it "the largest monetary settlement in the history of the District of Rhode Island."Assistant Attorney General Brett A. Shumate of the Justice Department's Civil Division, said, "Companies operating online marketplaces - whether based in the United States or abroad - must implement appropriate safeguards to prevent bad actors from exploiting their platforms. If they fail to do so, the Department will hold them accountable."The settlement marks the latest US action against Alibaba after the US Department of Defense in June added the company to its list of "Chinese military companies" under Section 1260H of the National Defense Authorization Act, alongside Baidu (HKG:9888), BYD (HKG:1211, SHE:002594), Nio (HKG:9866), WuXi AppTec (HKG:2359, SHA:603259), Robosense Technology (HKG:2498) and more.Last week, Alibaba sued the Pentagon, seeking to overturn the designation and accusing the department of acting without factual basis or fair process in branding it as a threat to national security."The determinations have no basis in fact or law... To label Alibaba a 'Chinese military company' is to brand it an instrument of the Chinese military and a threat to US national security," Alibaba wrote.

HKG:9988
Alibaba, US Payments Partner to Pay $600 Million in Drug-Import Probe
US Markets

Alibaba, US Payments Partner to Pay $600 Million in Drug-Import Probe

Alibaba Group (HKG:9988) and its US payments processor, AUS Merchant Services, agreed to pay a combined $600 million to resolve an investigation by the US Justice Department into illegal pharmaceutical sales on the company's e-commerce platforms.The Chinese tech and e-commerce firm admitted that between January 2016 and December 2024, it failed to prevent roughly 80,000 product sales on Alibaba.com and AliExpress.com that involved unlawful imports of pharmaceuticals, controlled substances, listed chemicals and pill presses, according to a Wednesday notice from the Justice Department.In a statement issued to, Alibaba described the settlement as a "mutually satisfactory resolution with U.S. regulators.""This settlement reflects a thorough regulatory process with Alibaba's full cooperation and our commitment to best-in-class standards of control, policies, and measures against non-compliant product sales."The products involved in the investigation have a combined gross merchandise value exceeding $200 million, the DOJ said, adding that federal agents made more than 40 undercover purchases of illegal drugs and counterfeiting equipment during the probe.Separately, AUS admitted that from January 2020 to December 2023, it accepted US dollar-denominated wire and credit-card payments on behalf of overseas Alibaba merchants.Under a non-prosecution agreement, Alibaba will pay a $125 million criminal penalty and forfeit $200 million, while AUS, formerly known as Alipay US, will pay an $85 million penalty and forfeit $190 million.First Assistant U.S. Attorney Charles C. Calenda for the District of Rhode Island called it "the largest monetary settlement in the history of the District of Rhode Island."Alibaba did not immediately respond to' request for comment.Assistant Attorney General Brett A. Shumate of the Justice Department's Civil Division, said, "Companies operating online marketplaces - whether based in the United States or abroad - must implement appropriate safeguards to prevent bad actors from exploiting their platforms. If they fail to do so, the Department will hold them accountable."The settlement marks the latest US action against Alibaba after the US Department of Defense in June added the company to its list of "Chinese military companies" under Section 1260H of the National Defense Authorization Act, alongside Baidu (HKG:9888), BYD (HKG:1211, SHE:002594), Nio (HKG:9866), WuXi AppTec (HKG:2359, SHA:603259), Robosense Technology (HKG:2498) and more.Last week, Alibaba sued the Pentagon, seeking to overturn the designation and accusing the department of acting without factual basis or fair process in branding it as a threat to national security."The determinations have no basis in fact or law... To label Alibaba a 'Chinese military company' is to brand it an instrument of the Chinese military and a threat to US national security," Alibaba wrote.

HKG:9988